EOM 1352: Fri 7 June 2024, 11:36
Media Pack
News

Current Edition

Volume 17 Issue 1
Discovery Park: Wed 13 November 2024, 10:35
ramusmedical
Current features

A CRO Should be the Partner that Gives Full Visibility on a Gene Therapy Trials Path

Ahead of ARVO 2025 next week where Emmes is poised to launch the first dedicated ophthalmology clinical trial technology platform, we spoke with Saqib Parkar, Managi...
2 May 2025 Current features
Continue Reading →
Current features

Expert Predictions for 2025: Spotlight on Efficiency, AI, Regulatory, Risk and Better Communications

In 2024 the life sciences sector experienced high levels of cost pressure that drove process transformation in regulatory functions and smarter use of data and human...
17 April 2025 Current features | Volume 17 Issue 1
Continue Reading →
Current features

Visualisation Approaches Coming to Light: Advances in Optical Imaging

Amidst the “burgeoning” interest in developing novel optical imaging drugs and imaging devices to assist various standard surgical procedures, the US Food and Drug A...
17 April 2025 Current features | Volume 17 Issue 1
Continue Reading →
Current features

How Technology will Shape Pharma in 2025: Predictions from Veeva

As we advance through 2025, biopharma companies are increasingly using artificial intelligence (AI) and new data tools to improve commercial performance and make res...
17 April 2025 Current features | Volume 17 Issue 1
Continue Reading →
Current features

Addressing Disparities in Clinical Research Participation in Genetically Based Rare Paediatric and Neurodevelopmental Diseases

We are at an important inflection point in our identification and understanding of genetically based diseases, particularly rarer paediatric-onset disorders that imp...
17 April 2025 Current features | Volume 17 Issue 1
Continue Reading →
Current features

Imaging: Advancing Biomarker Research for Alzheimer’s Disease Diagnosis

Insights from the Bio-Hermes Trial A New Perspective on Alzheimer's Research Alzheimer's disease (AD) presents a significant challenge, not only for those diagnos...
17 April 2025 Current features | Volume 17 Issue 1
Continue Reading →
Current features

Expert Insight Q&A: Advancing Oncology Therapies with Highly Potent APIs

Q1: Why are highly potent active pharmaceutical ingredients (HPAPIs) playing a transformative role in oncology drug development? A: The rise of precision oncology...
17 April 2025 Current features | Volume 17 Issue 1
Continue Reading →
Current features

Facilitating the Adoption of Digitalisation in Medications Adherence Monitoring

Effective monitoring of medication adherence is vital for the success of any clinical trial. Yet too often archaic, biased methods are used for compliance monitoring...
17 April 2025 Current features | Volume 17 Issue 1
Continue Reading →
Current features

Malaysia: The Hub for Medical Device Trials

Over the years, medical device has undergone significant transformation, with the use of evolving technological tools such as artificial intelligence (AI), machine l...
17 April 2025 Current features | Volume 17 Issue 1
Continue Reading →
Current features

Navigating Protocol Development in Early Phase Trials

While less resource-intensive than pivotal trials, early phase trials often involve significant scientific uncertainty. Information on a therapy’s side effects, beha...
16 April 2025 Current features | Volume 17 Issue 1
Continue Reading →
Catalyst: Fri 8 November 2024, 14:16
Biosynth: Wed 13 November 2024, 10:18

jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2025, All Rights Reserved – Powered by Teksyte